151 related articles for article (PubMed ID: 11284642)
1. Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management.
Karunajeewa H; Siebert D; Hammond R; Garland S; Kelly H
Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):23-8. PubMed ID: 11284642
[TBL] [Abstract][Full Text] [Related]
2. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
[TBL] [Abstract][Full Text] [Related]
3. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
[TBL] [Abstract][Full Text] [Related]
6. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.
Guidozzi F; Ballot D; Rothberg AD
J Reprod Med; 1994 Jan; 39(1):36-8. PubMed ID: 8169914
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
8. The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania.
Mirambo MM; Maliki F; Majigo M; Mushi MF; Moremi N; Seni J; Matovelo D; Mshana SE
BMC Pregnancy Childbirth; 2017 Jun; 17(1):176. PubMed ID: 28592274
[TBL] [Abstract][Full Text] [Related]
9. Seroinfection of Antibodies to
Cubas-Alarcón D; Guevara-Vásquez GM; Suclupe-Campos DO; Castro-Martínez S; Aguilar-Gamboa FR; Failoc-Rojas VE
Infect Dis Obstet Gynecol; 2024; 2024():8844325. PubMed ID: 38883209
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of anti-Toxoplasma gondii antibodies in pregnant women in seven hospitals in Buenos Aires area. Comparison 2006 vs. 2017].
Messina MT; Schneider MV; Carral L; Outón E; Pari M; Rodríguez M; Daquarti J; Amoia GG; Nadal M; Freuler C; Kaufer F
Medicina (B Aires); 2019; 79(6):433-437. PubMed ID: 31829944
[TBL] [Abstract][Full Text] [Related]
11. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland.
Morris A; Croxson M
N Z Med J; 2004 Feb; 117(1189):U770. PubMed ID: 15014559
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study.
Iddawela D; Vithana SMP; Ratnayake C
BMC Public Health; 2017 Dec; 17(1):930. PubMed ID: 29202747
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and risk factors for Toxoplasma gondii infection among pregnant women in Northeast Iran.
Babaie J; Amiri S; Mostafavi E; Hassan N; Lotfi P; Esmaeili Rastaghi AR; Golkar M
Clin Vaccine Immunol; 2013 Nov; 20(11):1771-3. PubMed ID: 24006138
[TBL] [Abstract][Full Text] [Related]
14. Seropositivity of Toxoplasmosis in Pregnant Women by ELISA at Minia University Hospital, Egypt.
Kamal AM; Ahmed AK; Abdellatif MZ; Tawfik M; Hassan EE
Korean J Parasitol; 2015 Oct; 53(5):605-10. PubMed ID: 26537040
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Toxoplasma gondii Among Pregnant Women in Northeast India.
Borkakoty B; Biswas D; Jakharia A; Mahanta J
J Assoc Physicians India; 2016 Oct; 64(10):24-28. PubMed ID: 27766799
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
17. Detection of specific IgG antibody production in vivo in infants with congenital HIV, parvovirus B19 or Toxoplasma gondii infection.
Gerritsen EJ; Dijkstra NH; Van Elsacker-Niele AM; Salimans MM; Goudsmit J; Boer K; Van Knapen F; Stegagno M; Cohen BJ; Rotmans JP
Immunodeficiency; 1993; 4(1-4):145-8. PubMed ID: 8167690
[No Abstract] [Full Text] [Related]
18. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Lebanese Pregnant Women.
Nahouli H; El Arnaout N; Chalhoub E; Anastadiadis E; El Hajj H
Vector Borne Zoonotic Dis; 2017 Dec; 17(12):785-790. PubMed ID: 29064352
[TBL] [Abstract][Full Text] [Related]
20. TORCH agents in pregnant Saudi women.
Ghazi HO; Telmesani AM; Mahomed MF
Med Princ Pract; 2002; 11(4):180-2. PubMed ID: 12424411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
